alpha-aminopyridine has been researched along with Nervous System Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busquet, N; Diaz, MJ; Gonzalez, MI; Lam, PM; Laoprasert, M; Raol, YH; Sampath, D; White, AM | 1 |
| Ishibashi, K; Ishii, K; Kameyama, M; Miura, Y; Toyohara, J | 1 |
| Cortese, F; De Giglio, L; Pennisi, EM | 1 |
| Compter, A; de Waard, Q; Gafer, H; van den Heuvel, M | 1 |
| Gavaldà, A; Lehner, MD; Pagès, L | 1 |
| Althaus, M; Hanschmann, A; Klein, T; Magerl, W; Treede, RD | 1 |
| Haley, TJ | 1 |
| Lawson, K | 1 |
| Bowe, CM; Veale, K | 1 |
| Campbell, GA; Davis, KL; Haroutunian, V; Kanof, PD; Tsuboyama, GK | 1 |
3 review(s) available for alpha-aminopyridine and Nervous System Disorders
| Article | Year |
|---|---|
PDE4 inhibitors: a review of current developments (2005 - 2009).
Topics: Aminopyridines; Animals; Benzamides; Clinical Trials as Topic; Cyclopropanes; Drug Design; Humans; Inflammation; Nervous System Diseases; Patents as Topic; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors | 2009 |
Physical and biological properties of pyrilamine.
Topics: Aminopyridines; Animals; Carcinogens; Chemical Phenomena; Chemistry; Chemistry, Physical; Humans; Immunity; Kinetics; Mutagens; Nervous System Diseases; Pyrilamine; Structure-Activity Relationship; Teratogens; Time Factors | 1983 |
Is there a role for potassium channel openers in neuronal ion channel disorders?
Topics: Aminopyridines; Animals; Anticonvulsants; Antihypertensive Agents; Ataxia; Carbamates; Diazoxide; Epilepsy; Humans; Ion Channels; Isaacs Syndrome; Membrane Potentials; Mice; Mice, Neurologic Mutants; Mutation; Nervous System Diseases; Neuroprotective Agents; Parkinson Disease; Phenylenediamines; Potassium Channels | 2000 |
1 trial(s) available for alpha-aminopyridine and Nervous System Disorders
| Article | Year |
|---|---|
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Topics: Aminopyridines; Analgesics; Capsaicin; Cross-Over Studies; Cyclopentanes; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hyperalgesia; Injections, Intradermal; Nervous System Diseases; Pain; Physical Stimulation; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2008 |
6 other study(ies) available for alpha-aminopyridine and Nervous System Disorders
| Article | Year |
|---|---|
Effects of a potassium channel opener on brain injury and neurologic outcomes in an animal model of neonatal hypoxic-ischemic injury.
Topics: Aminopyridines; Animals; Animals, Newborn; Anticonvulsants; Brain; Brain Injuries; Carotid Arteries; Cognition; Disease Models, Animal; Hand Strength; Hypoxia; Hypoxia-Ischemia, Brain; Male; Maze Learning; Motor Skills; Nervous System Diseases; Neuroprotection; Neuroprotective Agents; Potassium Channels; Quality of Life; Rats; Seizures | 2020 |
Head-to-Head Comparison of the Two MAO-B Radioligands, 18F-THK5351 and 11C-L-Deprenyl, to Visualize Astrogliosis in Patients With Neurological Disorders.
Topics: Aminopyridines; Carbon Radioisotopes; Female; Gliosis; Humans; Ligands; Male; Monoamine Oxidase; Nervous System Diseases; Positron-Emission Tomography; Quinolines; Selegiline | 2021 |
Aminopiridines in the treatment of multiple sclerosis and other neurological disorders.
Topics: 4-Aminopyridine; Aminopyridines; Humans; Lambert-Eaton Myasthenic Syndrome; Multiple Sclerosis; Nervous System Diseases; Potassium Channel Blockers; Quality of Life | 2020 |
Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases.
Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Crizotinib; Female; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Progression-Free Survival; Pyrazoles; Remission Induction; Treatment Outcome | 2019 |
Sensitivity to 4-aminopyridine observed in mammalian sciatic nerves during acute pyridoxine-induced sensory neuropathy and recovery.
Topics: 4-Aminopyridine; Action Potentials; Acute Disease; Aminopyridines; Animals; Female; Nerve Fibers, Myelinated; Nervous System Diseases; Pyridoxine; Rats; Rats, Inbred Strains; Reaction Time; Sciatic Nerve; Sensation; Spinal Nerve Roots | 1988 |
Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
Topics: 4-Aminopyridine; Alzheimer Disease; Aminopyridines; Animals; Behavior, Animal; Brain; Disease Models, Animal; Fetus; Growth Substances; Humans; Nerve Growth Factors; Nerve Tissue; Nerve Tissue Proteins; Nervous System Diseases; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Somatostatin | 1986 |